Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

rTMS Intervention for DMPFC Treatment of Treatment-Resistant Depression Under the Guidance of Personalized Brain Functional Area Dissection (pBFS) Technology

NCT06350396 is registered in ClinicalTrials.gov with Changping Laboratory as lead sponsor.

NCT NCT06350396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06350396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
rTMS Intervention for DMPFC Treatment of Treatment-Resistant Depression Under the Guidance of Personalized Brain Functional Area Dissection (pBFS) Technology
Lead sponsor
Changping Laboratory
Phase
Not applicable
Overall status
Unknown status
Start date
April 17, 2024
Completion date
June 30, 2025
Enrollment
270 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, treatment resistant depression